Home » Leading Edge Robotics News » J&J Launches Robotic Surgery Company

J&J Launches Robotic Surgery Company

Scott Huennekens, Verb Surgical's President and CEO. (Photo credit: Verb Surgical)
Scott Huennekens, Verb Surgical’s President and CEO. (Photo credit: Verb Surgical)

Johnson & Johnson’s Ethicon and Verily Life Sciences LLC (formerly Google Life Sciences) has formed a surgical robotics company called Verb Surgical Inc. The company hopes to use machine learning, robotic surgery, instrumentation, advanced visualization, and data analytics to improve patient outcomes, lower costs, and greater hospital efficiency.

“We believe Verb Surgical has the potential to change the future of surgery, not just robotic surgery,” said Gary Pruden, Worldwide Chairman, Johnson & Johnson Medical Devices. “The team has already made meaningful progress on the robotics platform, which is being developed for application across a host of surgical specialties.” Ethicon, which has deep expertise in minimally invasive surgery and advanced instrumentation, is developing surgical instruments for Verb Surgical’s new robotics-assisted platform.

In the coming years, Verb Surgical aims to develop a comprehensive surgical solutions platform that will incorporate leading-edge robotic capabilities and best-in-class medical device technology for operating room professionals. The goal of Verb Surgical is to develop these new technologies in partnership with surgeons and hospitals to enable better patient outcomes, improve access to minimally invasive surgery, and achieve greater hospital efficiency.

Verb Surgical will be headquartered in Mountain View, Calif. Under Mr. Huennekens’ leadership, the company will be overseen by a Board of Directors, which will include members from Ethicon, Johnson & Johnson Innovation, LLC, Verily and Google.

“I’m very excited about the possibilities that we can realize through our new surgical solutions company,” said Scott Huennekens, President and CEO, Verb Surgical. “By maximizing the distinct capabilities of these two market-leading companies, we aim to develop novel technologies and solutions to help improve the standard of care around the world. Our name speaks for itself. We are a company dedicated to action and to making a difference in people’s lives, in partnership with surgeons globally.”

Leave a Reply

Your email address will not be published. Required fields are marked *